Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.

Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.

Item
http://www.wikidata.org/entity/Q34093272
Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune DysfunctionThe potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivoRecent developments in targeting carbonic anhydrase IX for cancer therapeuticsIBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy.Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice.Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivoOncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinoma.Intracellular trafficking of new anticancer therapeutics: antibody-drug conjugates.Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim.Tumour acidosis: from the passenger to the driver's seat.Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.Enhanced Therapeutic Activity of Non-Internalizing Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination With Targeted Interleukin-2.Hypoxia-targeted gold nanorods for cancer photothermal therapy.
P2860

Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.

Item
http://www.wikidata.org/entity/Q34093272
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@ast
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@en
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@nl
type
label
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@ast
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@en
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@nl
prefLabel
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@ast
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@en
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Therapeutic mechanism and effi ...... ng human carbonic anhydrase 9.
@en
P2093
P304
P31
P356
10.1158/1535-7163.MCT-11-0523
P433
P478
P577
P698
P921